Log in

NASDAQ:MSONMisonix Stock Price, Forecast & News

+0.57 (+4.24 %)
(As of 08/11/2020 04:00 PM ET)
Today's Range
Now: $14.00
50-Day Range
MA: $13.29
52-Week Range
Now: $14.00
Volume65,200 shs
Average Volume96,329 shs
Market Capitalization$243.07 million
P/E RatioN/A
Dividend YieldN/A
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Read More
Misonix logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars

Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Current SymbolNASDAQ:MSON



Sales & Book Value

Annual Sales$38.85 million
Book Value$2.25 per share


Net Income$-7,390,000.00


Market Cap$243.07 million
Next Earnings Date9/3/2020 (Confirmed)
OptionableNot Optionable
+0.57 (+4.24 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Misonix (NASDAQ:MSON) Frequently Asked Questions

How has Misonix's stock been impacted by COVID-19 (Coronavirus)?

Misonix's stock was trading at $10.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MSON stock has increased by 31.1% and is now trading at $14.00.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Misonix?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Misonix

When is Misonix's next earnings date?

Misonix is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020.
View our earnings forecast for Misonix

How can I listen to Misonix's earnings call?

Misonix will be holding an earnings conference call on Thursday, September 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) posted its quarterly earnings data on Monday, May, 11th. The medical equipment provider reported ($0.34) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.30) by $0.04. The medical equipment provider had revenue of $17.90 million for the quarter. Misonix had a negative return on equity of 9.13% and a negative net margin of 19.18%.
View Misonix's earnings history

What guidance has Misonix issued on next quarter's earnings?

Misonix updated its fourth quarter 2020 Pre-Market earnings guidance on Friday, July, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.5-13.5 million, compared to the consensus revenue estimate of $8.11 million.

What price target have analysts set for MSON?

3 equities research analysts have issued 1-year target prices for Misonix's stock. Their forecasts range from $18.00 to $23.00. On average, they anticipate Misonix's share price to reach $21.00 in the next year. This suggests a possible upside of 50.0% from the stock's current price.
View analysts' price targets for Misonix

Has Misonix been receiving favorable news coverage?

News headlines about MSON stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Misonix earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Misonix

Are investors shorting Misonix?

Misonix saw a increase in short interest in February. As of February 15th, there was short interest totaling 510,700 shares, an increase of 18.8% from the January 31st total of 430,000 shares. Based on an average daily volume of 89,000 shares, the days-to-cover ratio is presently 5.7 days.
View Misonix's Short Interest

Who are some of Misonix's key competitors?

What other stocks do shareholders of Misonix own?

Who are Misonix's key executives?

Misonix's management team includes the following people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
  • Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
  • Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

Who are Misonix's major shareholders?

Misonix's stock is owned by many different retail and institutional investors. Top institutional investors include Acuitas Investments LLC (1.02%), Mesirow Financial Investment Management Inc. (0.13%), New York State Common Retirement Fund (0.09%), Ingalls & Snyder LLC (0.07%) and SG Americas Securities LLC (0.05%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Sharon W Klugewicz and Stavros G Vizirgianakis.
View institutional ownership trends for Misonix

Which major investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC.
View insider buying and selling activity for Misonix

Which major investors are buying Misonix stock?

MSON stock was acquired by a variety of institutional investors in the last quarter, including Acuitas Investments LLC, New York State Common Retirement Fund, SG Americas Securities LLC, and Mesirow Financial Investment Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Sharon W Klugewicz, and Stavros G Vizirgianakis.
View insider buying and selling activity for Misonix

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $14.00.

How big of a company is Misonix?

Misonix has a market capitalization of $243.07 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe.

What is Misonix's official website?

The official website for Misonix is www.misonix.com.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.